ReShape Lifesciences Total Current Liabilities 2015-2024 | RSLS

ReShape Lifesciences total current liabilities from 2015 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.

ReShape Lifesciences Total Current Liabilities 2015-2024 | RSLS

ReShape Lifesciences total current liabilities from 2015 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$233.1B
Intuitive Surgical (ISRG)$171.3B
Alcon (ALC)$47.7B
IQVIA Holdings (IQV)$44.2B
IDEXX Laboratories (IDXX)$42.1B
Edwards Lifesciences (EW)$40.7B
DexCom (DXCM)$27.8B
STERIS (STE)$23.5B
SONOVA HOLDING (SONVY)$20.8B
Waters (WAT)$19.8B
Hologic (HOLX)$19B
Sysmex ADR (SSMXY)$12.3B
Fresenius Medical Care AG KGaA (FMS)$12.2B
Teleflex (TFX)$11.4B
Globus Medical (GMED)$9.4B
Penumbra (PEN)$7.6B
Glaukos (GKOS)$6.7B
Masimo (MASI)$6.1B
TransMedics (TMDX)$5.2B
PROCEPT BioRobotics (PRCT)$4.3B
Integer Holdings (ITGR)$4.3B
Tandem Diabetes Care (TNDM)$2.8B
LivaNova (LIVN)$2.8B
Veracyte (VCYT)$2.6B
Inari Medical (NARI)$2.6B
Elekta AB (EKTAY)$2.6B
Nihon Kohden (NHNKY)$2.5B
RxSight (RXST)$2B
Integra LifeSciences Holdings (IART)$1.4B
Pulse Biosciences (PLSE)$1.2B